Association Between Triglyceride Glucose-waist Height Ratio Index and Cardiovascular Disease in Middle-aged and Older Chinese Individuals: a Nationwide Cohort Study
Overview
Endocrinology
Affiliations
Background: The triglyceride-glucose (TyG) index and its combination with obesity indicators can predict cardiovascular diseases (CVD). However, there is limited research on the relationship between changes in the triglyceride glucose-waist height ratio (TyG-WHtR) and CVD. Our study aims to investigate the relationship between the change in the TyG-WHtR and the risk of CVD.
Methods: Participants were from the China Health and Retirement Longitudinal Study (CHARLS). CVD was defined as self-reporting heart disease and stroke. Participants were divided into three groups based on changes in TyG-WHtR using K-means cluster analysis. Multivariable binary logistic regression analysis was used to examine the association between different groups (based on the change of TyG-WHtR) and CVD. A restricted cubic spline (RCS) regression model was used to explore the potential nonlinear association of the cumulative TyG-WHtR and CVD events.
Results: During follow-up between 2015 and 2020, 623 (18.8%) of 3312 participants developed CVD. After adjusting for various potential confounders, compared to the participants with consistently low and stable TyG-WHtR, the risk of CVD was significantly higher in participants with moderate and increasing TyG-WHtR (OR 1.28, 95%CI 1.01-1.63) and participants with high TyG-WHtR with a slowly increasing trend (OR 1.58, 95%CI 1.16-2.15). Higher levels of cumulative TyG-WHtR were independently associated with a higher risk of CVD events (per SD, OR 1.27, 95%CI 1.12-1.43).
Conclusions: For middle-aged and older adults, changes in the TyG-WHtR are independently associated with the risk of CVD. Maintaining a favorable TyG index, effective weight management, and a reasonable waist circumference contribute to preventing CVD.
Qiu J, Li J, Xu S, Zeng H, Zhang Y, Yang S Cardiovasc Diabetol. 2025; 24(1):114.
PMID: 40065337 PMC: 11895255. DOI: 10.1186/s12933-025-02674-z.
Mo D, Zhang P, Zhang M, Dai H, Guan J Cardiovasc Diabetol. 2025; 24(1):116.
PMID: 40065297 PMC: 11895360. DOI: 10.1186/s12933-025-02675-y.
Hong J, Zhang R, Tang H, Wu S, Chen Y, Tan X Cardiovasc Diabetol. 2025; 24(1):98.
PMID: 40022122 PMC: 11871812. DOI: 10.1186/s12933-025-02662-3.
Liu J, Fu Y, Liang P, Song Z, Li Y, Wu H Cardiovasc Diabetol. 2025; 24(1):96.
PMID: 40022121 PMC: 11871838. DOI: 10.1186/s12933-025-02587-x.
Xu J, Cai D, Jiao Y, Liao Y, Shen Y, Shen Y Cardiovasc Diabetol. 2025; 24(1):93.
PMID: 40022080 PMC: 11871683. DOI: 10.1186/s12933-025-02657-0.